在高血压患者中,初始治疗用含有半剂量四倍治疗与标准剂量双疗法 (QUADUAL) 的单片囊:随机,盲目,交叉试验的研究方案
Xiexiong Zhao1, Ye Chen1, Guoping Yang2
1Department of Cardiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
American heart journal
|June 5, 2023
概括
本研究将半剂量四倍疗法与标准剂量双疗法进行比较,用于初始高血压治疗. 目标是确定四倍疗法是否提供更好的血压控制和更少的副作用.
科学领域:
- 心血管医学 心血管医学
- 临床药理学 临床药理学
- 高血压研究 高血压研究
背景情况:
- 建议使用联合抗高血压疗法,而不是单一治疗.
- 双重组合治疗在高血压指南中得到了肯定.
- 低剂量四重疗法对双重组合的优势尚不清楚.
研究的目的:
- 为了比较半剂量四重疗法与标准剂量双重疗法的疗效和安全性.
- 评估轻度至中度高血压 (140-179/90-109 mm Hg) 的初始治疗方法.
主要方法:
- 随机,双盲,交叉临床试验 (QUADUAL试验).随机,双盲,交叉临床试验.
- 90名患者被随机分配到两组,在4周后切换疗法,并进行2周的洗.
- 低剂量四倍疗法 (伊尔贝沙坦75mg+美托普罗罗尔23.75mg+安乐滴2.5mg+因达帕米德1.25mg) 与标准剂量双倍疗法 (伊尔贝沙坦150mg+安乐滴5mg) 的比较.
主要成果:
- 该研究正在进行中,预计将于2023年8月完成.
- 主要结局是评估血压降低和不良影响.
- 二次结果将分析患者的安全性和治疗耐受性.
结论:
- 该QUADUAL试验将提供关于初始四倍低剂量治疗的有效性的见解.
- 结果将为临床实践提供有关最佳初始抗高血压策略的信息.
- 这项研究探讨了低剂量四倍和标准双重抗高血压疗法之间的未知比较.
相关概念视频
01:16Crossover Experiments
2.9K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.9K
02:07Blind Procedures
10.7K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.7K
01:11Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
19
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
19
01:01Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
01:27Coronary Artery Disease V: Interprofessional Care
11
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
11